ChemicalBook > CAS DataBase List > Sifalimumab

Sifalimumab

Product Name
Sifalimumab
CAS No.
1006877-41-3
Chemical Name
Sifalimumab
Synonyms
Sifalimumab;MDX-1103|||MEDI-545;Sifalimumab (anti-IFNa1);Research Grade Sifalimumab;Research Grade Sifalimumab(DHB94501)
CBNumber
CB28080806
Formula Weight
0
MOL File
Mol file
More
Less

Sifalimumab Property

form 
Liquid
color 
Colorless to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Sifalimumab Chemical Properties,Usage,Production

Uses

Sifalimumab (MEDI-545) is an anti-IFNα monoclonal antibody. Sifalimumab suppresses the abnormal immune activity by binding to multiple interferon-alpha (IFNα) subtypes. Sifalimumab can be used in systemic lupus erythematosus (SLE) research[1][2].

in vivo

Sifalimumab (subcutaneous injection; 30 mg/kg and 3 μg/g) treatment shows therapeutic effect and attenuates the lymphocyte infiltration[2].

Animal Model:Wild-type male BALB/c mice[2]
Dosage:30 mg/kg and 3 μg/g
Administration:Subcutaneous injection; 30 mg/kg and 3 μg/g
Result:Prevented the increase CpG-induced, decreasing CD86 fluorescence intensity by 1.9-fold (P < 0.05).
Showed a potentially therapeutic effect attenuating the CpG-induced lymphocyte infiltration.
Attenuated the CD45 increase (P<0.05).

References

[1] Merrill JT, et al. Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study. Ann Rheum Dis. 2011 Nov;70(11):1905-13. DOI:10.1136/ard.2010.144485
[2] La Maestra S, et al. Brain microglia activation induced by intracranial administration of oligonucleotides and its pharmacological modulation. Drug Deliv Transl Res. 2018 Oct;8(5):1345-1354. DOI:10.1007/s13346-018-0535-3

Sifalimumab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Sifalimumab Suppliers

TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
Aladdin Scientific
Tel
Email
tp@aladdinsci.com
Country
United States
ProdList
57505
Advantage
58

1006877-41-3, SifalimumabRelated Search:


  • Sifalimumab
  • Research Grade Sifalimumab(DHB94501)
  • Sifalimumab (anti-IFNa1)
  • MDX-1103|||MEDI-545
  • Research Grade Sifalimumab
  • 1006877-41-3